| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.4M | +124.7% |
| Cost of Revenue | $990K | +36.6% |
| Gross Profit | $374K | +416.9% |
| R&D Expense | $1.3M | -37.1% |
| SG&A Expense | $1.2M | -47.5% |
| Operating Income | -$6.1M | +29.8% |
| Net Income | -$6.5M | +27.4% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $52K | -98.7% |
| Accounts Receivable | $196K | -44.2% |
| Inventory | $249K | -21.0% |
| Current Assets | $535K | -88.9% |
| Total Assets | $615K | -87.6% |
| Current Liabilities | $1.1M | +311.0% |
| Total Liabilities | $1.1M | +311.0% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$3.3M | +42.7% |
| Capital Expenditures | $27K | -37.2% |
| Investing Cash Flow | -$27K | +37.2% |
| Financing Cash Flow | -$685K | — |
| Free Cash Flow | -$3.3M | +42.6% |
| Stockholders' Equity |
| -$503K |
| -110.7% |